ClinicalTrialsFeeds.org

NIH Clinical Trials Results via RSS

483 Clinical Trials for: Middle School, Page 15 of 25

Hide Studies Not Seeking New Volunteers

283

Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma

Condition(s): Recurrent Adenoid Cystic Carcinoma of the Oral Cavity; Recurrent Salivary Gland Cancer; Salivary Gland Adenoid Cystic Carcinoma; Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity; Stage IVA Salivary Gland Cancer; Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity; Stage IVB Salivary Gland Cancer; Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity Last Updated: March 18, 2013Suspended